Related Experiment Video
Updated: Nov 7, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.7K
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zheying Zhang1, Manman Lu1, Yu Qin1
1Department of Pathology, Xinxiang Medical University, Xinxiang, China.
Frontiers in Immunology
|May 3, 2021
Summary
Cancer immunotherapy harnesses the immune system to fight tumors. Tumor neoantigens, derived from mutations or viruses, offer a promising new approach for cancer vaccines currently in clinical trials.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer immunotherapy has advanced significantly, notably with immune checkpoint inhibitors (ICIs) targeting CTLA-4, PD-1, and PD-L1.
- Tumor neoantigens, arising from viral integration or mutations, are highly specific to cancer cells and elicit a strong immune response.
Purpose of the Study:
- To review the latest advancements in cancer immunotherapy, focusing on tumor-specific neoantigens.
- To discuss the classification, identification, and synthesis of neoantigens.
- To explore the role, prospects, and challenges of neoantigens in cancer treatment.
Main Methods:
- Literature review of recent studies on cancer immunotherapy and neoantigens.
- Analysis of neoantigen classification, identification, and synthesis methodologies.
- Evaluation of neoantigen-based vaccines in clinical trials.
Main Results:
- Immune checkpoint blockade has revolutionized cancer treatment.
- Tumor neoantigens demonstrate high immunogenicity and tumor specificity.
- Neoantigen vaccines are emerging as a promising therapeutic strategy in various solid tumors.
Conclusions:
- Neoantigens represent a significant frontier in cancer immunotherapy.
- Further research is needed to overcome existing challenges in neoantigen-based therapies.
- Neoantigen vaccines hold substantial promise for future cancer treatment strategies.
Related Concept Videos
01:27Tumor Immunotherapy
807
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
807
01:30Cancer Vaccines
603
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603
02:38Mitogens and the Cell Cycle
7.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
02:07Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K